# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
1 | 05-14-2024 | 03-31-2024 | 10-Q | |
2 | 03-26-2024 | 12-31-2023 | 10-K | |
3 | 11-14-2023 | 09-30-2023 | 10-Q | |
4 | 10-20-2023 | 06-30-2023 | 10-Q |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Chardan Capital analyst Keay Nakae maintains Allurion Technologies (NYSE:ALUR) with a Buy and maintains $5 price target.
Allurion Technologies (NYSE:ALUR) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $...
New data demonstrates 80% sustained weight loss at three years with the Allurion Program and initial positive outcomes of a nov...